NCT01563588

Brief Summary

Many breast cancer patients (BCP) will gain weight during chemotherapy and about 10% of them are able to find back to their initial weight after all treatments are finished. Other studies have shown that overweight at diagnosis was associated to a twice higher risk of relapse while a weight gain during treatments increased by 30% to 50% the risk of relapse. In western countries, 75% of BCP have insufficient physical activity. Dietary and activity programs seem to be able to significantly reduce the mortality risk after breast cancer. The investigators performed a prospective randomized trial consisting in dietary counseling, physical training and physiotherapy in hydrothermal centers. Intervention were delivered in small group session lasting 12 days. SPA cares were offered to patients. Patients in the control group also received dietary counseling given by a dietetician inside anticancer hospital, and were asked to perform more physical activities. Main endpoints of the trial addressed quality of life (SF36) one year after inclusion, weight reduction, anxiety/depression (HAD), sleep quality and long term compliance to instructions. An economic study was associated to the protocol, for volunteers only.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
251

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2008

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2008

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2010

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

February 22, 2012

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 27, 2012

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2013

Completed
Last Updated

December 28, 2015

Status Verified

December 1, 2015

Enrollment Period

1.8 years

First QC Date

February 22, 2012

Last Update Submit

December 23, 2015

Conditions

Keywords

breast cancerchemotherapyfirst line treatmenttreatments include a chemotherapylast treatment not performed more than 9 months earlier

Outcome Measures

Primary Outcomes (1)

  • Quality of life (SF36)

    Quality of life was measured with the SF36 questionnaire before randomization, at 6, 12, 18, 24 and 36 months. The difference at one year was the main endpoint.

    one year after inclusion

Secondary Outcomes (4)

  • Anxiety/depression scores (HAD)

    inclusion, 6, 12, 18, 24, 36 months

  • Weight and morphometric measures

    inclusion, 6, 12, 18, 24, 36 months

  • Sleep quality

    inclusion, 6, 12, 18, 24, 36 months

  • economic figures

    during 2 years after inclusion

Study Arms (2)

dietary and physical training

EXPERIMENTAL

12 days session of physical training, dietary education, physiotherapy and SPA cares in small group (less than 12 women) delivered in hydrothermal centers

Behavioral: dietaty education, physical training, physiotherapy and SPA cares

control

NO INTERVENTION

dietary counseling by a dietetician in the anticancer hospital

Interventions

12 days session of daily physical training, dietary education, physiotherapy and SPA cares in small group (less than 12 women) delivered in hydrothermal centers

dietary and physical training

Eligibility Criteria

Age18 Years - 70 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • breast cancer
  • treatment including a chemotherapy
  • in complete remission
  • signed consent

You may not qualify if:

  • metastatic disease
  • relapse
  • women enable to have physical activity
  • heart disease or any pathology preventing physical activity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Centre Jean Perrin

Clermont-Ferrand, Puy de Dome, 63011, France

Location

Pole Santé-République

Clermont-Ferrand, Puy de Dome, 63100, France

Location

Related Links

MeSH Terms

Conditions

Breast Neoplasms

Interventions

Physical Therapy Modalities

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

TherapeuticsRehabilitation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor Yves-Jean Bignon

Study Record Dates

First Submitted

February 22, 2012

First Posted

March 27, 2012

Study Start

December 1, 2008

Primary Completion

October 1, 2010

Study Completion

October 1, 2013

Last Updated

December 28, 2015

Record last verified: 2015-12

Locations